REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Stack Library

Russian Brain Stack

Cognitive Enhancementintermediate

88

synergy

88
Peptides

2

Avg Daily mcg

900

Level

intermediate

Added

May 17, 2026

Overview

The Russian Brain Stack is one of the most pharmacologically elegant peptide combinations in the longevity and cognitive optimization space. Both Semax and Selank were developed at the Institute of Molecular Genetics of the Russian Academy of Sciences and have been prescribed in Russia and Eastern Europe for decades for cognitive enhancement, anxiety, and neurological conditions. Their combination earns a synergy score of 88/100. Semax is a synthetic heptapeptide analog of ACTH (adrenocorticotropic hormone) fragment 4-7. It powerfully upregulates BDNF (Brain-Derived Neurotrophic Factor) — the primary growth factor for neurons — and enhances dopaminergic and serotonergic signaling. The practical effects are significant: improved focus, working memory, learning speed, and mental clarity. It also demonstrates neuroprotective properties, reducing oxidative stress and inflammation in neural tissue. Selank is a synthetic analog of the endogenous tetrapeptide tuftsin, with added stability for intranasal delivery. It modulates GABA signaling and serotonin systems to produce anxiolytic (anti-anxiety) effects without sedation or dependence. Unlike benzodiazepines, Selank does not impair cognition — it enhances it while reducing the anxiety and stress that typically interfere with focus and performance. The synergy is complementary by design: Semax provides the cognitive upregulation (BDNF, focus, memory) while Selank provides the anxiolytic stabilization (calm, reduced cortisol reactivity, stress resilience). Together, they produce a state of calm, focused, high-performance cognition — alertness without anxiety, focus without jitteriness — that neither achieves alone. Both are administered intranasally, which provides efficient CNS delivery without first-pass metabolism.

Dosing Protocol

Semax

Every day· intranasal

600 mcg

per dose

Selank

Every day· intranasal

300 mcg

per dose

Goals & Evidence

Focus and concentrationMemory and learningAnxiety reductionCalm cognitionNeuroplasticity
Evidence tier:Human Data

Warnings

  • Semax and Selank are prescription medications in Russia. Regulatory status varies by country. Not FDA-approved in the US.

Disclaimer: This stack is community-submitted and for research purposes only. PeptideVault does not verify the safety or efficacy of submitted stacks. Always consult a qualified healthcare professional before using any peptide protocol.